Novavax
NVAX
#5485
Rank
โ‚น122.81 B
Marketcap
โ‚น755.81
Share price
-3.68%
Change (1 day)
3.12%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: โ‚น122.81 Billion

As of February 2026 Novavax has a market cap of โ‚น122.81 Billion. This makes Novavax the world's 5485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น122.81 B23.27%
2025โ‚น99.63 B-12.44%
2024โ‚น113.78 B139.7%
2023โ‚น47.46 B-34.36%
2022โ‚น72.31 B-91.02%
2021โ‚น805.14 B55.09%
2020โ‚น519.15 B5553.97%
2019โ‚น9.18 B-81.44%
2018โ‚น49.46 B66.42%
2017โ‚น29.72 B27.98%
2016โ‚น23.22 B-84.57%
2015โ‚น150.52 B67.7%
2014โ‚น89.76 B36%
2013โ‚น66.00 B331.1%
2012โ‚น15.30 B99.78%
2011โ‚น7.66 B-36.62%
2010โ‚น12.09 B-2.3%
2009โ‚น12.37 B96.94%
2008โ‚น6.28 B-22.39%
2007โ‚น8.09 B-27.85%
2006โ‚น11.22 B18.33%
2005โ‚น9.48 B69.81%
2004โ‚น5.58 B-41.12%
2003โ‚น9.48 B204.61%
2002โ‚น3.11 B-80.35%
2001โ‚น15.84 B80.73%
2000โ‚น8.76 B136.43%
1999โ‚น3.70 B271.02%
1998โ‚น0.99 B-57.65%
1997โ‚น2.36 B79.13%
1996โ‚น1.31 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Novavax was reported to be:

โ‚น122.81 Billion
by Nasdaq info icon info icon
โ‚น122.81 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น25.965 T 21,041.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น13.230 T 10,672.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น51.606 T 41,918.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น9.734 T 7,825.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น191.89 B 56.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น151.02 B 22.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น9.46 B-92.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น1.87 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น150.06 B 22.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น55.59 B-54.73%๐Ÿ‡บ๐Ÿ‡ธ USA